MarinaBayRXMarinaBayRX

Farxiga
Farxiga

0.27
A clinical formulation indicated for Diabetes. Physiological action facilitates glucose excretion via the kidneys to achieve stable glycemic targets.
Ingredient
Dapagliflozin
Category
Diabetes
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Dapagliflozin
Reference Brand
Forxiga
Product Origin
Generic Alternative
Reference Manufacturer
AstraZeneca
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Diabetes Management, Heart Health
Product Category
SGLT2 Inhibitor
Pharmacological Class
SGLT2 Inhibitor
Manufacturer Description
Utilized to manage blood sugar and address heart and kidney risks to alleviate metabolic strain and support improved cardiovascular health in adult patients.
Mechanism of Action
Dapagliflozin inhibits the SGLT2 protein in the kidneys. By preventing the reabsorption of glucose into the bloodstream, it causes excess sugar to be removed from the body through the urine, which also helps reduce blood pressure.
Route of Administration
Oral
Onset Time
Steady state in 2 days
Duration
24 hours
Contraindications
Severe renal impairment (specific stages), Dialysis, History of hypersensitivity, Type 1 diabetes
Severe Adverse Events
Diabetic ketoacidosis, Severe kidney injury, Fournier's gangrene, Urosepsis, Severe dehydration
Common Side Effects
Increased thirst, Increased urination
Uncommon Side Effects
Urinary tract infections, Genital yeast infections, Nausea, Dizziness, Back pain
Drug Interactions
Insulin, Sulfonylureas, Diuretics, Rifampin, ACE inhibitors
Pregnancy Safety Warnings
Not recommended during the second and third trimesters.
Age Restrictions
Approved for adults; pediatric use established in some countries for T2DM.
Storage Guidelines
Store at room temperature.
Related Products
Empagliflozin, Canagliflozin, Ertugliflozin
Information for Farxiga is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories